{"id":"clm_AF5A88F5634C","entity":"vertex-pharmaceuticals","predicate":"shares_outstanding","value":"258,094,815 shares","value_json":{"fp":"Q2","fy":2023,"accn":"0000875320-23-000021","form":"10-Q","filed":"2023-08-02","period":"Q2 FY2023","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2023-07-31","valid_to":"2023-10-31","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Vertex Pharmaceuticals shares outstanding: 258,094,815 shares\", as of 2023-07-31 (until 2023-10-31). Claim clm_AF5A88F5634C, https://asof.is/claim/clm_AF5A88F5634C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532023000021/0000875320-23-000021-index.htm.","url":"https://asof.is/claim/clm_AF5A88F5634C","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_63DBD5A352EB","supersedes":["clm_D7E4C28F5ECB"],"first_seen_at":"2026-11-08T17:02:27.400953+00:00","updated_at":"2026-11-08T17:02:34.884621+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000021/0000875320-23-000021-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-02T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-08-02"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}